Prostaglandin I2 sodium salt

• Catalog No.: 82478
• CAS Number: 61849-14-7
• M. F.: C20H31NaO5
• M. W.: 374.44691
• Purity: ≥98.0% (HPLC)

SYNONYMS

• IUPAC name: sodium 5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-en-1-yl]-hexahydro-2H-cyclopenta[b]furan-3-ylidene]pentanoate
• IUPAC Traditional name: sodium 5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-en-1-yl]-hexahydrocyclopenta[b]furan-3-ylidene]pentanoate
• Synonyms: Prostacyclin sodium salt; Epoprostenol 钠; Epoprostenol sodium salt; PGI2-Na; (5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt

DATABASE IDS

• EC Number: 263-273-7
• CAS Number: 61849-14-7
• MDL Number: MFCD00135629
• Beilstein Number: 6472195

PROPERTIES

• Empirical Formula (Hill Notation): C20H31NaO5
• Purity: ≥98.0% (HPLC)
• Solubility: ethanol: soluble50 mg/mL, clear, colorless to faintly yellow
• GHS Signal Word: Warning
• GHS Hazard statements: H302-H312-H332
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P280
• Risk Statements: 20/21/22
• Safety Statements: 22-26-36
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
Prostacyclin therapy improves hemodynamics in pulmonary arterial hypertension.1

Description (简体中文)

Biochem/physiol Actions
Prostacyclin therapy improves hemodynamics in pulmonary arterial hypertension.1